4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001181431-10-014577
Options or other derivatives
- President and CEO acquired 563,250 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Anzalone Christopher Richard · President and CEO
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2010-03-04 | Grant or award : show line 1 in the form Stock Option | +563,250 | 1,714,750 | D |
Loading xslF345X03/rrd268942.xml…